loadpatents
name:-0.075084924697876
name:-0.052148818969727
name:-0.0094790458679199
Tsurushita; Naoya Patent Filings

Tsurushita; Naoya

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tsurushita; Naoya.The latest application filed is for "bifunctional molecules for treatment of immune disorders".

Company Profile
8.59.65
  • Tsurushita; Naoya - Palo Alto CA
  • TSURUSHITA; Naoya - Mountain View CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bifunctional Molecules For Treatment Of Immune Disorders
App 20220306753 - Tsurushita; Naoya ;   et al.
2022-09-29
Bispecific Antibodies for Activation of Immune Cells
App 20220251214 - Tsurushita; Naoya ;   et al.
2022-08-11
Bispecific antibodies which bind PD-L1 and GITR
Grant 11,332,532 - Tsurushita , et al. May 17, 2
2022-05-17
Multimeric Hybrid Fc Proteins for Replacement of IVIG
App 20220002361 - TSURUSHITA; Naoya ;   et al.
2022-01-06
Humanized anti-CLL-1 antibodies
Grant 11,072,662 - Jiang , et al. July 27, 2
2021-07-27
Anti-OX40 antibodies and methods of using the same
Grant 10,851,173 - Liu , et al. December 1, 2
2020-12-01
Methods And Compositions For The Generation And Use Of Humanized Conformation-specific Phosphorylated Tau Antibodies
App 20200362022 - KUMAR; Shankar ;   et al.
2020-11-19
Antibodies to TIGIT
App 20200297844 - Tso; J. Yun ;   et al.
2020-09-24
Bispecific Antibodies for Activation of Immune Cells
App 20200165341 - Tsurushita; Naoya ;   et al.
2020-05-28
Antibodies to TIGIT
Grant 10,537,633 - Tso , et al. Ja
2020-01-21
Anti-ox40 Antibodies And Methods Of Using The Same
App 20190100596 - LIU; Yong-Jun ;   et al.
2019-04-04
Anti-human TROP-2 antibody having an antitumor activity in vivo
Grant 10,202,461 - Nakamura , et al. Feb
2019-02-12
Anti-OX40 antibodies and methods of using the same
Grant 10,196,450 - Liu , et al. Fe
2019-02-05
Humanized Anti-cll-1 Antibodies
App 20180355044 - Jiang; Ying-Ping ;   et al.
2018-12-13
Hybrid constant regions
Grant 10,053,517 - Tso , et al. August 21, 2
2018-08-21
Antibodies To Tigit
App 20170281764 - Tso; J. Yun ;   et al.
2017-10-05
Anti-ox40 Antibodies And Methods Of Using The Same
App 20170267773 - LIU; Yong-Jun ;   et al.
2017-09-21
Anti-OX40 antibodies and methods of using the same
Grant 9,695,246 - Liu , et al. July 4, 2
2017-07-04
Humanized anti-IL-20 antibody and uses thereof
Grant 9,683,036 - Chang , et al. June 20, 2
2017-06-20
Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece
Grant 9,540,442 - Tsurushita , et al. January 10, 2
2017-01-10
Nucleic acid encoding anti-OX40 antibodies
Grant 9,527,917 - Liu , et al. December 27, 2
2016-12-27
Hybrid Constant Regions
App 20160369012 - Tso; J. Yun ;   et al.
2016-12-22
Anti-human Trop-2 Antibody Having An Antitumor Activity In Vivo
App 20160333110 - NAKAMURA; Koji ;   et al.
2016-11-17
Anti-human TROP-2 antibody having an antitumor activity in vivo
Grant 9,427,464 - Nakamura , et al. August 30, 2
2016-08-30
Hybrid constant regions
Grant 9,382,319 - Tso , et al. July 5, 2
2016-07-05
Anti-hDlk-1 antibody having an antitumor activity in vivo
Grant 9,303,086 - Nakamura , et al. April 5, 2
2016-04-05
Anti-ox40 Antibodies And Methods Of Using The Same
App 20160068604 - LIU; Yong-Jun ;   et al.
2016-03-10
Anti-ox40 Antibodies And Methods Of Using The Same
App 20150315281 - LIU; Yong-Jun ;   et al.
2015-11-05
Anti-OX40 antibodies and methods of treating cancer
Grant 9,163,085 - Liu , et al. October 20, 2
2015-10-20
Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease
App 20150175681 - Ma; Dangshe ;   et al.
2015-06-25
Antibodies to CD122
Grant 9,028,830 - Tso , et al. May 12, 2
2015-05-12
Humanized Anti-IL-20 Antibody And Uses Thereof
App 20150118711 - CHANG; MING-SHI ;   et al.
2015-04-30
Anti-OX40 antibodies and methods of using the same
Grant 9,006,399 - Liu , et al. April 14, 2
2015-04-14
Antibodies for the treatment of Clostridium difficile-associated infection and disease
Grant 8,986,697 - Ma , et al. March 24, 2
2015-03-24
Hybrid Constant Regions
App 20150073130 - Tso; J. Yun ;   et al.
2015-03-12
Expression vectors
Grant 8,969,539 - Tsurushita , et al. March 3, 2
2015-03-03
Hybrid constant regions
Grant 8,952,134 - Tso , et al. February 10, 2
2015-02-10
Antibodies Or Fusion Proteins Multimerized Via Homomultimerizing Peptide
App 20150038682 - Tsurushita; Naoya ;   et al.
2015-02-05
Anti-human Sema4a Antibodies Useful To Treat Disease
App 20150004178 - Liu; Yong-Jun ;   et al.
2015-01-01
Anti-ox40 Antibodies And Methods Of Using The Same
App 20140308276 - Liu; Yong-Jun ;   et al.
2014-10-16
Hybrid Constant Regions
App 20140294825 - Tso; J. Yun ;   et al.
2014-10-02
Humanized anti-.alpha. 9 integrin antibodies and the uses thereof
Grant 8,821,863 - Kumar , et al. September 2, 2
2014-09-02
Anti-hdlk-1 Antibody Having An Antitumor Activity In Vivo
App 20140193432 - NAKAMURA; Koji ;   et al.
2014-07-10
Generation, expression and characterization of the humanized K33N monoclonal antibody
Grant 8,735,552 - Kumar , et al. May 27, 2
2014-05-27
Antibodies Or Fusion Proteins Multimerized Via Cysteine Mutation And A Mu Tailpiece
App 20140037621 - Tsurushita; Naoya ;   et al.
2014-02-06
Alteration of Fc-fusion protein serum half-lives by mutagenesis
Grant 8,624,007 - Hinton , et al. January 7, 2
2014-01-07
Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
Grant 8,617,829 - Kumar , et al. December 31, 2
2013-12-31
Anti-human Trop-2 Antibody Having An Antitumor Activity In Vivo
App 20130344509 - NAKAMURA; Koji ;   et al.
2013-12-26
Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
Grant 8,614,296 - Kumar , et al. December 24, 2
2013-12-24
Humanized anti-IL-20 antibody and uses thereof
Grant 8,597,647 - Chang , et al. December 3, 2
2013-12-03
Humanized Anti-il-20 Antibody And Uses Thereof
App 20130315893 - CHANG; Ming-Shi ;   et al.
2013-11-28
Humanized antibodies that sequester amyloid beta peptide
Grant 8,591,894 - Holtzman , et al. November 26, 2
2013-11-26
Anti-ox40 Antibodies And Methods Of Using The Same
App 20130280275 - Liu; Yong-Jun ;   et al.
2013-10-24
Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease
App 20130202618 - Ma; Dangshe ;   et al.
2013-08-08
Hybrid Constant Regions
App 20130089547 - Tso; J. Yun ;   et al.
2013-04-11
Humanized Antibodies Specific For Amino Acid Sequence Rgd Of An Extracellular Matrix Protein And The Uses Thereof
App 20120219503 - Kumar; Shankar ;   et al.
2012-08-30
Mammalian cell-based immunoglobulin display libraries
Grant 8,163,546 - Akamatsu , et al. April 24, 2
2012-04-24
Generation, Expression And Characterization Of The Humanized K33n Monoclonal Antibody
App 20110300139 - Kumar; Shankar ;   et al.
2011-12-08
Antibodies To Cd122
App 20110250213 - Tso; J. Yun ;   et al.
2011-10-13
Anti-hDlk-1 antibody having an antitumor activity in vivo
Grant 8,017,118 - Nakamura , et al. September 13, 2
2011-09-13
Alteration Of Fc-fusion Protein Serum Half-lives By Mutagenesis
App 20110183412 - Hinton; Paul R. ;   et al.
2011-07-28
Humanized Antibodies That Sequester Amyloid Beta Peptide
App 20110158986 - Holtzman; David M. ;   et al.
2011-06-30
Treatment of inflammatory bowel diseases with anti-IP-10 antibodies
Grant 7,935,793 - Balasa , et al. May 3, 2
2011-05-03
Humanized Antibodies Specific For Amino Acid Sequence Rgd Of An Extracellular Matrix Protein And The Uses Thereof
App 20110091386 - Kumar; Shankar ;   et al.
2011-04-21
Humanized antibodies that sequester amyloid beta peptide
Grant 7,892,545 - Holtzman , et al. February 22, 2
2011-02-22
Mammalian Cell-based Immunoglobulin Display Libraries
App 20110008883 - AKAMATSU; YOSHIKO ;   et al.
2011-01-13
Humanized Anti-alpha 9 Integrin Antibodies And The Uses Thereof
App 20100329980 - Kumar; Shankar ;   et al.
2010-12-30
Anti-CCR5 antibody
Grant 7,851,600 - Olson , et al. December 14, 2
2010-12-14
Alteration of Fc-fusion protein serum half-lives by mutagenesis
Grant 7,732,570 - Hinton , et al. June 8, 2
2010-06-08
Tethered vectors for cell surface immunoglobulin display
Grant 7,732,195 - Akamatsu , et al. June 8, 2
2010-06-08
Anti-CCR5 antibody
Grant 7,666,419 - Olson , et al. February 23, 2
2010-02-23
Expression vectors
App 20090320149 - Tsurushita; Naoya ;   et al.
2009-12-24
Anti-hdlk-1 Antibody Having An Antitumor Activity In Vivo
App 20090299038 - Nakamura; Koji ;   et al.
2009-12-03
Humanized Antibodies That Sequester Amyloid Beta Peptide
App 20090238821 - Holtzman; David M. ;   et al.
2009-09-24
Mammalian Cell-based Immunoglobulin Display Libraries
App 20090111126 - Akamatsu; Yoshiko ;   et al.
2009-04-30
Alteration of Fc-fusion protein serum half-lives by mutagenesis
App 20080287657 - Hinton; Paul R. ;   et al.
2008-11-20
Anti-CCR5 antibody
App 20080107595 - Olson; William C. ;   et al.
2008-05-08
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
Grant 7,365,168 - Hinton , et al. April 29, 2
2008-04-29
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
Grant 7,361,740 - Hinton , et al. April 22, 2
2008-04-22
Treatment Of Inflammatory Bowel Diseases With Anti-Ip-10 Antibodies
App 20080063646 - Balasa; Balaji ;   et al.
2008-03-13
Humanized anti-.beta.antibodies
Grant 7,318,923 - Tsurushita , et al. January 15, 2
2008-01-15
Amphiregulin antibodies and their use to treat cancer and psoriasis
Grant 7,223,393 - Landolfi , et al. May 29, 2
2007-05-29
Alteration of Fc-fusion protein serum half-lives by mutagenesis
Grant 7,217,798 - Hinton , et al. May 15, 2
2007-05-15
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
Grant 7,217,797 - Hinton , et al. May 15, 2
2007-05-15
Humanized antibodies that sequester abeta peptide
Grant 7,195,761 - Holtzman , et al. March 27, 2
2007-03-27
Humanized antibodies to gamma-interferon
Grant 7,183,390 - Vasquez , et al. February 27, 2
2007-02-27
Anti-CCR5 antibody
App 20070031408 - Olson; William C. ;   et al.
2007-02-08
Anti-CCR5 antibody
Grant 7,122,185 - Olson , et al. October 17, 2
2006-10-17
Antibodies against CTLA4 and uses therefor
App 20060165706 - Carreno; Beatriz M. ;   et al.
2006-07-27
Antibodies against CTLA4
Grant 7,034,121 - Carreno , et al. April 25, 2
2006-04-25
Humanized antibodies that sequester abeta peptide
App 20060039906 - Holtzman; David M. ;   et al.
2006-02-23
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
App 20050276799 - Hinton, Paul R. ;   et al.
2005-12-15
Alteration of Fc-fusion protein serum half-lives by mutagenesis
App 20050226864 - Hinton, Paul R. ;   et al.
2005-10-13
Humanized antibodies
App 20050090648 - Tsurushita, Naoya ;   et al.
2005-04-28
Interleukin-1 beta antibodies
App 20050075488 - Bright, Stuart Willis ;   et al.
2005-04-07
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
App 20050032114 - Hinton, Paul R. ;   et al.
2005-02-10
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
App 20050014934 - Hinton, Paul R. ;   et al.
2005-01-20
Humanized chicken antibodies
App 20040260068 - Tsurushita, Naoya ;   et al.
2004-12-23
Assay method for alzheimer's disease
App 20040248197 - Holtzman, David M. ;   et al.
2004-12-09
Amphiregulin antibodies and their use to treat cancer and psoriasis
App 20040210040 - Landolfi, Nicholas F. ;   et al.
2004-10-21
Anti-abeta antibodies
App 20040192898 - Jia, Audrey Yunhua ;   et al.
2004-09-30
Humanized antibodies that sequester Abeta peptide
App 20040043418 - Holtzman, David M. ;   et al.
2004-03-04
Anti-CCR5 antibody
App 20030228306 - Olson, William C. ;   et al.
2003-12-11
Humanized antibodies to gamma-interferon
App 20020091240 - Vasquez, Maximiliano ;   et al.
2002-07-11
Antibodies against CTLA4 and uses therefor
App 20020039581 - Carreno, Beatriz M. ;   et al.
2002-04-04
Humanized antibodies to .gamma.-interferon
Grant 6,329,511 - Vasquez , et al. December 11, 2
2001-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed